| Daniel E Greenan, DPM | |
|
17820 1st Ave S, Suite 101, Burien, WA 98148-1723 | |
| (206) 248-3668 | |
| (206) 244-2499 |
| Full Name | Daniel E Greenan |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 17820 1st Ave S, Burien, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780677047 | NPI | - | NPPES |
| P00311179 | Other | WA | RR MEDICARE |
| 5823620001 | Other | WA | DME SUPPLIER NUMBER |
| 1116169 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | PO00000701 (Washington) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO00000701 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highline Medical Center | Burien, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Neuronal Ceroid Liposfuscinosis (NCL), often referred to as Batten disease, is a rare and fatal neurodegenerative disorder that afflicts infants and young children. NCL is caused by a deficiency of a lysosomal enzyme, and is a relatively rare disease, affecting an estimated 2 to 4 of every 100,000 babies born in the U.S. Although NCLs are classified as rare diseases, they often affect more than one child in families that carry the defective gene, and tragically, are always fatal.
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"As states complain about the burden of expanding health care to millions of poor Americans under the new federal health-care law, a study released Wednesday suggests their claims may be overstated. The issue is the cost of expanding Medicaid ... and the report from the Kaiser Commission on Medicaid and the Uninsured says states are likely to reap huge benefits for relatively little cost, and may even end up in the black."
› Verified 6 days ago
| Provider Name | Franciscan Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Neuronal Ceroid Liposfuscinosis (NCL), often referred to as Batten disease, is a rare and fatal neurodegenerative disorder that afflicts infants and young children. NCL is caused by a deficiency of a lysosomal enzyme, and is a relatively rare disease, affecting an estimated 2 to 4 of every 100,000 babies born in the U.S. Although NCLs are classified as rare diseases, they often affect more than one child in families that carry the defective gene, and tragically, are always fatal.
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"As states complain about the burden of expanding health care to millions of poor Americans under the new federal health-care law, a study released Wednesday suggests their claims may be overstated. The issue is the cost of expanding Medicaid ... and the report from the Kaiser Commission on Medicaid and the Uninsured says states are likely to reap huge benefits for relatively little cost, and may even end up in the black."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel E Greenan, DPM 17820 1st Ave S, Suite 101, Burien, WA 98148-1794 Ph: (206) 592-5000 | Daniel E Greenan, DPM 17820 1st Ave S, Suite 101, Burien, WA 98148-1723 Ph: (206) 248-3668 |
News Archive
Neuronal Ceroid Liposfuscinosis (NCL), often referred to as Batten disease, is a rare and fatal neurodegenerative disorder that afflicts infants and young children. NCL is caused by a deficiency of a lysosomal enzyme, and is a relatively rare disease, affecting an estimated 2 to 4 of every 100,000 babies born in the U.S. Although NCLs are classified as rare diseases, they often affect more than one child in families that carry the defective gene, and tragically, are always fatal.
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.
"As states complain about the burden of expanding health care to millions of poor Americans under the new federal health-care law, a study released Wednesday suggests their claims may be overstated. The issue is the cost of expanding Medicaid ... and the report from the Kaiser Commission on Medicaid and the Uninsured says states are likely to reap huge benefits for relatively little cost, and may even end up in the black."
› Verified 6 days ago
Dr. Ryan Jeffrey Stone, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 16233 Sylvester Rd Sw Ste G10, Burien, WA 98166 Phone: 206-242-6553 Fax: 206-246-0468 | |
Foot And Ankle Specialists, Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 17820 1st Ave S, Suite 101, Burien, WA 98148 Phone: 206-248-3668 Fax: 206-244-2499 | |
Dr. Daniel K Johnson, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 17820 1st Ave S, Suite 101, Burien, WA 98148 Phone: 206-248-3668 Fax: 206-244-2499 | |
Byron L Hutchinson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd #g10, Highline Foot Ankle Clinic, Burien, WA 98166 Phone: 206-242-6553 Fax: 206-246-0468 | |
Taylor Avery Sann, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw Ste G10, Burien, WA 98166 Phone: 206-242-6553 Fax: 206-341-1250 |